References
- Guzman MG, Gubler DJ, Izquierdo A, Martinez E, Halstead SB. Dengue infection. Nat Rev Dis Primers. 2016; 2:16055. doi: 10.1038/nrdp.2016.55
- Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. 2016; 16:935–41.
- Vanlerberghe V, Villegas E, Oviedo M, Baly A, Lenhart A, McCall PJ, Van der Stuyft P. Evaluation of the effectiveness of insecticide treated materials for household level dengue vector control. PLoS Negl Trop Dis. 2011; 5:e994. doi: 10.1371/journal.pntd.0000994
- Loroño-Pino MA, García-Rejón JE, Machain-Williams C, Gomez-Carro S, Nuñez-Ayala G, Nájera-Vázquez Mdel R, et al. Towards a Casa Segura: a consumer product study of the effect of insecticide-treated curtains on Aedes aegypti and dengue virus infections in the home. Am J Trop Med Hyg. 2013; 89:385–97.
- Kirkpatrick BD, Whitehead SS, Pierce KK, Tibery CM, Grier PL, Hynes NA, et al. The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model. Sci Transl Med. 2016; 8:330ra36. doi: 10.1126/scitranslmed.aaf1517
- Thomas SJ, Yoon I-K. A review of Dengvaxia®: development to deployment. Hum Vaccin Immunother. 2019; 15:2295–314.
- Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med. 2018; 379:327–40.
- Soo K-M, Khalid B, Ching S-M, Chee H-Y. Meta-analysis of dengue severity during infection by different dengue virus serotypes in primary and secondary infections. PLoS One. 2016; 11:e0154760. doi: 10.1371/journal.pone.0154760
- Capeding MR, de Boer M, Damaso S, Guignard A. A prospective cohort study assessing the burden of dengue illness among household members in Alaminos, Laguna in the Philippines. Asian Biomed (Res Rev News). 2021; 15:213–22.
- Raafat N, Blacksell SD, Maude RJ. A review of dengue diagnostics and implications for surveillance and control. Trans R Soc Trop Med Hyg. 2019; 113:653–60.